Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany (Orphanet Journal of Rare Diseases, (2022), 17, 1, (276), 10.1186/s13023-022-02420-8)

Research output: Contribution to specialist publication › Corrections (errata and retractions) › peer-review

Contributors

  • Risdiplam Compassionate Use Program Group - (Author)
  • Department of Neurology
  • University Hospital Gießen and Marburg
  • Ulm University Medical Center
  • University Hospital Münster
  • University Hospital Carl Gustav Carus Dresden
  • University of Bonn Medical Center
  • National Center for Tumor Diseases (NCT) Heidelberg
  • Roche Pharma AG
  • LVR University Hospital Essen

Abstract

Following publication of the original article [1], we have been notified that there is a typographical error in the Fig. 1 text. It should be as per below: Figure 1: “111 patients received ≥ 1 risdiplam dose.

Details

Original languageEnglish
Pages387
Volume17
Issue number1
JournalOrphanet journal of rare diseases
Publication statusPublished - 25 Oct 2022
Peer-reviewedYes
No renderer: customAssociatesEventsRenderPortal,dk.atira.pure.api.shared.model.researchoutput.ContributionToPeriodical

External IDs

PubMedCentral PMC9597989
Scopus 85140679457

Keywords